Diagnosis of periprosthetic joint infection: The utility of biomarkers in 2023

Yükleniyor...
Küçük Resim

Tarih

2023

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

MDPI

Erişim Hakkı

Attribution 4.0 International
info:eu-repo/semantics/openAccess

Özet

Periprosthetic joint infection (PJI) is a rare yet devastating complication following total joint arthroplasty (TJA). Early and accurate diagnosis of PJI is paramount in order to maximize the chances of successful treatment. However, we are yet to identify a single "gold standard" test for the diagnosis of PJI. As a result, the diagnosis of PJI is often challenging. Currently, the 2018 ICM definition of PJI is the only validated diagnostic criteria available. This article will review the importance of serum and synovial biomarkers in the diagnosis of PJI. In addition, it will provide a brief overview of the emerging modalities for the identification of infections in this setting.

Açıklama

Anahtar Kelimeler

Periprosthetic Joint Infection, Serum, Synovial Fluid, Marker

Kaynak

Antibiotics-Basel

WoS Q Değeri

Q1

Scopus Q Değeri

Q1

Cilt

12

Sayı

6

Künye

Yılmaz, M. K., Abbaszadeh, A., Tarabichi, S., Azboy, İ. ve Parvizi, J. (2023). Diagnosis of periprosthetic joint infection: The utility of biomarkers in 2023. Antibiotics-Basel, 12(6). https://dx.doi.org/10.3390/antibiotics12061054